fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer’s disease

Written by | 20 Apr 2025

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the… read more.

Anti-obesity drugs benefit kidney transplant recipients with type 2 diabetes

Written by | 19 Mar 2025

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study… read more.

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

Written by | 19 Feb 2025

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart… read more.

SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission

Written by | 9 Feb 2025

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher… read more.

Lack of essential vitamins and minerals common in people with type 2 diabetes

Written by | 5 Feb 2025

Micronutrient deficiency, whereby levels of vitamins and minerals essential for healthy bodily function are far too low, is common in people with type 2 diabetes, finds a pooled… read more.

FDA approves Ozempic to reduce the risk of kidney disease worsening, kidney failure and death due to CV disease in adults with type 2 diabetes and CKD – Novo Nordisk

Written by | 5 Feb 2025

Novo Nordisk announced that the FDA has approved Ozempic (semaglutide injection) to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to… read more.

What is metformin’s secret sauce?

Written by | 7 Jan 2025

Millions of people take metformin, a Type 2 diabetes medication that lowers blood sugar. The “wonder drug” has also been shown to slow cancer growth, improve COVID outcomes… read more.

Specific long term condition combinations have major role in NHS ‘winter pressures’

Written by | 17 Nov 2024

Specific combinations of long term conditions have a major role in the additional pressures the NHS faces every winter, because they are associated with significantly higher risks of … read more.

Tirzepatide associated with greater weight loss in women than men

Written by | 1 Oct 2024

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced… read more.

New blood test could be an early warning for child diabetes

Written by | 26 Sep 2024

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart… read more.

Innovative semaglutide hydrogel could reduce diabetes shots to once a month

Written by | 10 Sep 2024

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once… read more.

Red and processed meat consumption associated with higher type 2 diabetes risk, study of two million people finds

Written by | 27 Aug 2024

Meat consumption, particularly consumption of processed meat and unprocessed red meat, is associated with a higher type 2 diabetes risk, an analysis of data from 1.97 million participants,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.